『徳島大学 教育・研究者情報データベース (EDB)』---[学外] /
ID: Pass:

登録内容 (EID=164975)

EID=164975EID:164975, Map:0, LastModified:2013年11月27日(水) 13:39:00, Operator:[三木 ちひろ], Avail:TRUE, Censor:0, Owner:[三好 弘一], Read:継承, Write:継承, Delete:継承.
種別 (必須): 学術論文 (審査論文) [継承]
言語 (必須): 英語 [継承]
招待 (推奨):
審査 (推奨):
カテゴリ (推奨):
共著種別 (推奨):
学究種別 (推奨):
組織 (推奨):
著者 (必須): 1. (英) Liu Yiyao (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
2.三好 弘一 ([徳島大学.放射線総合センター])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
3.中村 教泰
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
題名 (必須): (英) Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis by targeted functional nanoparticles  (日)    [継承]
副題 (任意):
要約 (任意): (英) The diagnosis and treatment of cancer or tumor at the cellular level will be greatly improved with the development of techniques that enable the delivery of analyte probes and therapeutic agents into cells and cellular compartments. Organic and inorganic nanoparticles that interface with biological systems have recently attracted widespread interest in the fields of biology and medicine. The new term nanomedicine has been used recently. Nanoparticles are considered to have the potential as novel intravascular or cellular probes for both diagnostic (imaging) and therapeutic purposes (drug/gene delivery), which is expected to generate innovations and play a critical role in medicine. Target-specific drug/gene delivery and early diagnosis in cancer treatment is one of the priority research areas in which nanomedicine will play a vital role. Some recent breakthroughs in this field recently also proved this trend. Nanoparticles for drug delivery and imaging have gradually been developed as new modalities for cancer therapy and diagnosis. In this article, we review the significance and recent advances of gene/drug delivery to cancer cells, and the molecular imaging and diagnosis of cancer by targeted functional nanoparticles.  (日)    [継承]
キーワード (推奨): 1. (英) Drug Delivery Systems (日) (読) [継承]
2. (英) Humans (日) (読) [継承]
3. (英) Models, Biological (日) (読) [継承]
4.ナノ医療 (nanomedicine) [継承]
5.ナノ粒子 (nanoparticles/->キーワード[ナノ粒子]) [継承]
6. (英) Nanostructures (日) (読) [継承]
7. (英) Neoplasms (日) (読) [継承]
8. (英) Pharmaceutical Preparations (日) (読) [継承]
9. (英) Quantum Dots (日) (読) [継承]
発行所 (推奨):
誌名 (必須): International Journal of Cancer ([国際対ガン連合])
(pISSN: 0020-7136, eISSN: 1097-0215)

ISSN (任意): 0020-7136
ISSN: 0020-7136 (pISSN: 0020-7136, eISSN: 1097-0215)
Title: International journal of cancer
Title(ISO): Int J Cancer
Supplier: Union for International Cancer Control
Publisher: Wiley
 (NLM Catalog  (Wiley  (Scopus  (CrossRef (Scopus information is found. [need login])
[継承]
[継承]
(必須): 120 [継承]
(必須): 12 [継承]
(必須): 2527 2537 [継承]
都市 (任意):
年月日 (必須): 西暦 2007年 6月 15日 (平成 19年 6月 15日) [継承]
URL (任意):
DOI (任意): 10.1002/ijc.22709    (→Scopusで検索) [継承]
PMID (任意): 17390371    (→Scopusで検索) [継承]
CRID (任意):
WOS (任意):
Scopus (任意):
評価値 (任意):
被引用数 (任意):
指導教員 (推奨):
備考 (任意): 1.(英) Article.Affiliation: Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, Sichuan, People's Republic of China. liuyiyao@hotmail.com  (日)    [継承]
2.(英) Article.PublicationTypeList.PublicationType: Journal Article  (日)    [継承]
3.(英) Article.PublicationTypeList.PublicationType: Research Support, Non-U.S. Gov't  (日)    [継承]
4.(英) Article.PublicationTypeList.PublicationType: Review  (日)    [継承]
5.(英) NumberOfReferences: 97  (日)    [継承]

標準的な表示

和文冊子 ● Yiyao Liu, Hirokazu Miyoshi and Michihiro Nakamura : Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis by targeted functional nanoparticles, International Journal of Cancer, Vol.120, No.12, 2527-2537, 2007.
欧文冊子 ● Yiyao Liu, Hirokazu Miyoshi and Michihiro Nakamura : Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis by targeted functional nanoparticles, International Journal of Cancer, Vol.120, No.12, 2527-2537, 2007.

関連情報

Number of session users = 0, LA = 1.26, Max(EID) = 392241, Max(EOID) = 1059776.